cover
Contact Name
Bayu Brahma
Contact Email
journal.cancer@gmail.com
Phone
+628176389956
Journal Mail Official
admin@indonesianjournalofcancer.or.id
Editorial Address
National Cancer Center - Dharmais Cancer Hospital Research and Development Building, 3rd-floor Jl. Letjen S. Parman Kav. 84-86, Slipi West Jakarta
Location
Kota adm. jakarta barat,
Dki jakarta
INDONESIA
Indonesian Journal of Cancer
ISSN : 19783744     EISSN : 23556811     DOI : https://www.doi.org/ 10.33371
Core Subject : Health, Science,
Indonesian Journal of Cancer is a peer-reviewed and open-access journal. This journal is published quarterly (in March, June, September, and December) by Dharmais Cancer Hospital - National Cancer Center. Submissions are reviewed under a broad scope of topics relevant to experimental and clinical cancer research. Articles are original research that needs to be disseminated and written in English. All submitted manuscripts will go through the double-blind peer review and editorial review before being granted acceptance for publication. The journal publishes original research articles, case reports, and review articles under the following categories: cancer management, cancer prevention, cancer etiology, epidemiology, molecular oncology, cancer diagnosis and therapy, tumor pathology, surgical oncology, medical oncology, radiation oncology, interventional radiology, as well as early detection.
Arjuna Subject : Kedokteran - Onkologi
Articles 562 Documents
The Clinical Evaluation and Survival Rate of Pediatric Sarcoma in Dr. Sardjito General Hospital, Yogyakarta, Indonesia Mulatsih, Sri; Hanifah, Atikah; Oktasari, Rizki
Indonesian Journal of Cancer Vol 18, No 4 (2024): December
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v18i4.1199

Abstract

Background: Pediatric sarcoma is a heterogeneous group of tumors and accounts for approximately 10% of childhood solid tumors. The most common soft tissue sarcoma is rhabdomyosarcoma, and the most common bone sarcomas are osteosarcoma and Ewing’s sarcoma. The prognosis for children with sarcoma depends on age, primary tumor site, tumor size, resectability, presence or absence of metastases, number of metastatic sites, presence or absence of regional lymph node involvement, histopathologic subtype, and in some cases, delivery of radiation therapy. This study aims to evaluate clinical signs, symptoms, and survival rates.Methods: We carried out a retrospective analysis of clinical data from sarcoma patients in Dr. Sardjito General Hospital to provide a reference for the design of future pediatric sarcomaspecific studies. Data from patients with sarcoma entered in Dr. Sardjito General Hospital from 2012 until 2017 was collected. Patients who had confirmed pediatric sarcoma diagnosis were eligible for samples at study entry. Clinical manifestations were assessed, and overall survival was calculated with Kaplan-Meier.Results: Among 400 patients coding with pediatric sarcoma, 154 were excluded because their medical records were broken and deleted, and 82 because the coding was not related to their diagnosis (non-pediatric sarcoma). Sixty patients were eligible for the analysis (28 men and 32 women, median age at diagnosis 13 years, range 0–18 years). Fifteen patients (25%) received chemotherapy, radiation, and surgery as a treatment, 16 patients (26.67%) received chemotherapy and surgery only, five patients (8.33%) received chemotherapy only, five patients (8.33%) received chemotherapy and radiation only, one patient (1.67%), and ten patients (16.67%) received surgery only. The most common primary tumor was located in the lower extremity (n = 29; 48.33%). At entry, metastases were mainly found in the lungs. The overall survival rate of pediatric sarcoma in Dr. Sardjito General Hospital was 19% or 88 months (95% CI median 48 months ± 4.658).Conclusions: This study revealed a diverse range of clinical presentations and a concerningly low overall survival rate. These findings highlight the need for further research to improve treatment strategies and outcomes for pediatric sarcoma, particularly focusing on factors influencing survival and addressing the high rate of metastatic disease.
Carotid Body Tumor: A Rare Case Report of a Neck Tumor Andinata, Bob; Marleen, Stella; Partahi, Jeremy Romeo
Indonesian Journal of Cancer Vol 18, No 4 (2024): December
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v18i4.1243

Abstract

Introduction: Commonly referred to as paragangliomas or glomus caroticum, carotid body tumors (CBT) are rare tumors that develop close to the carotid artery’s branching point and are generally benign. Only 0.6% of all head and neck tumors in humans are CBT, which are rare malignancies of chemical receptors. The surgical classification presented by Shamblin et al. is a significant turning point in assessing the resectability of these tumors. These tumors are frequently diagnosed and surgically prepared using magnetic resonance imaging, which provides crucial information for surgical planning. The purpose of this case report was to describe the diagnosis and treatment of CBT.Case Presentation: A 26-year-old woman with a carotid body tumor is presented. She had a painless, progressively growing bulge on the right side of her neck. The patient previously had a history of a lump appearing in the same location and was operated in 2015; the results of anatomic pathology were non-specific chronic lymphadenitis. The diagnosis was made based on history, and clinical and radiological examination findings. The results from the MRI were a mass in the right carotid bifurcation region to the right carotid space. Therefore, surgical excision was performed. Conclusions: Surgical excision was performed after the carotid body tumor was determined to be Type I according to Shamblin’s categorization. The conclusion of the histopathology report was histologic consistent with Schwannoma. The patient showed no signs of surgical complications. Comprehensive surgical methods reduce the possibility of complications and ensure a safe resection.n’s type I, surgical exicision
The Correlation Between Organophosphate Pesticide Exposure and Incidence of Prostate Cancer: A Systematic Review Octavia, Aulia Mega Nur; Wisudanti, Desie Dwi; Wulandari, Pipiet
Indonesian Journal of Cancer Vol 18, No 4 (2024): December
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v18i4.1112

Abstract

Background: Organophosphate is a type of pesticide that is widely used. However, organophosphates are a group of highly toxic chemicals. The World Health Organization (WHO) estimates that nearly 3 million individuals experience organophosphate poisoning annually. One of the cancers that can develop due to exposure to organophosphate pesticides is prostate cancer. Prostate cancer is the second most prevalent cancer among men. In Indonesia, new cases of prostate cancer reached 13.563, or 7.4% of all new cancer cases in men. This study aims to determine the correlation between organophosphate exposure and the incidence of prostate cancer.Methods: This study is a research with a systematic review design. The data in this study is secondary data obtained from research articles using SPICE criteria. Pubmed, Science Direct, Springer, and Google Scholar are the databases used. The used articles were articles published between 2012 and 2022. Critical assessment was carried out using the NewcastleOttawa Quality Assessment Scale (NOS) questionnaire.Results: A total of 2.149 articles were obtained, with a range of research years from 2012 to 2022. Then a duplication selection process was carried out, free and fulltext selection. This article used the NewcastleOttawa Quality Assessment Scale questionnaire to select eligibility, so 5 articles were obtained. Among all the articles that underwent critical evaluation, it was reported that a relationship exists between organophosphate exposure and the incidence of prostate cancer among farmers. Conclusions: The evidence of this reviewed study suggests a possible association between the incidence of prostate cancer and exposure to organophosphate pesticides.
A Rare Case of Primary Breast Lymphoma Priyono, Sasongko Hadi; Effendy, Effendy
Indonesian Journal of Cancer Vol 18, No 4 (2024): December
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v18i4.1132

Abstract

Introduction: Breast lymphoma (BL) is an uncommon type of extranodal non-Hodgkin lymphoma. Breast lymphoma is challenging to diagnose as its findings are not very specific and usually hard to differentiate from other breast carcinoma. There are no current authorized therapeutic guidelines to date because of the case rarity. In this report, we present a case of detected primary breast lymphoma in a 28-years woman which treated with systemic six cycles of R-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine (Oncovin), prednisone) chemotherapy, the response remained satisfying until the end of the cycle and no complications were reported.Case Presentation: A 28-year-old woman who had primary breast lymphoma, was treated and had a positive recovery. Clinical examination showed a hard, mobile, erythematous, ulcerating, necrotizing mass in the left breast, approximately 35 cm in the largest dimension. Mammae ultrasound revealed a hypoechoic mass located on the outer upper quadrant presumed malignant (BI-RADS 5). A core biopsy was performed, and an immunohistochemistry test revealed the CD45, CD20, and Ki-67 expression were positive, which finally diagnosed the case as a high-grade B-cell non-Hodgkin’s lymphomaResults: The patient was treated with systemic chemotherapy with six cycles of the R-CHOP protocol, which included administration of cyclophosphamide, doxorubicin, vincristine, rituximab, and prednisone. The patient response remained satisfying until the end of the cycle and no complications were reported.
Translation in Bahasa Indonesia and Linguistic Validation of Mastectomy Module of BREAST-Q: A Description of The Process Prajoko, Yan Wisnu; Korwa, Ivani Yunita; Junita, Dila
Indonesian Journal of Cancer Vol 18, No 4 (2024): December
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v18i4.1076

Abstract

Background: Breast-related Symptom Questionnaire (BREAST-Q) has been globally used and validated to measure the outcomes among women undergoing various breast surgery. There was a lack of tools to evaluate patient’s quality of life and satisfaction after mastectomy in Indonesia. In addition, most patients in Indonesia may feel reluctant to express their honest opinions regarding the post-operative outcome openly. Prior to this issue, this study aims to translate and validate the BREAST-Q Mastectomy Module into Bahasa Indonesia, which can be applied to the Indonesian population. Method: Primarily based on the guidelines from the International Society for Pharmacoeconomics and Outcome Research (ISPOR), the process includes preparation, forward translation, back translation, panel discussion, cognitive debriefing interview with 57 respondents, statistic evaluation of validity and reliability, and final consensus. Results: Two translators worked on two different forward translation, while a third translator handled the back translation. The translations were then discussed and reviewed to reach an agreement on the finalized version. Statistic evaluation showed Pearson’s r value 0.26 in all items, with Cronbach’s alpha range 0.72–0.92 ( 0.70). Bland-Altman plots comparison showed that the direction of the mean difference between score 1 and score 2 is close to zero. At the same time, the limits of agreements exceed the minimally detectable change for both scales, indicating all items are valid, reliable, and reflect the concepts of the BREAST-Q Mastectomy Module. The final version of the Bahasa Indonesia Translation is then approved by the Q-Portfolio team.Conclusion: The translation of BREAST-Q questionnaire Mastectomy Module in Bahasa Indonesia is valid and reliable. It is a suitable instrument to assess the quality of life of patients who underwent mastectomy in the Indonesian population.
Adult Hodgkin’s Lymphoma in Indonesian National Cancer Center Hospital: An Observational Study Tadjoedin, Hilman
Indonesian Journal of Cancer Vol 18, No 4 (2024): December
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v18i4.1273

Abstract

Background: Hodgkin’s lymphoma (HL) is a malignancy of lymphatic glands whose incidence is higher in Asia than in other continents and it is highly curable amongst other hematological malignancies. Our study aims to establish distribution data among HL patients in the Indonesian National Cancer Hospital.Method: A cohort retrospective was conducted from 2017 to 2021 on HL patients. Data on demographic and clinical characteristics were collected and described.Result: From 177 HL subjects, 52.5% were men with a median age of 32 years. B-symptoms occurred in 30.1% of subjects. Most subjects have great performance status (44%) and normal body mass index (39.6%). Comorbidities found were diabetes mellitus (10.3%) and hypertension (8.1%). By hematological examination, lactate dehydrogenase (LDH) level was found 85.7% more than 240 U/dL, hemoglobin (Hb) level 71.6% non-anemic, leukocytosis in 33.5%, and thrombocytosis in 59.4%. The disease stage is mostly in stage 2 (51%), with 19.2% having extra nodal lesions which are commonly found in bone marrow (32.2%). The outcome showed that 69.2% of subjects survived.Conclusion: In general, the majority of subjects were young adult males, with no B-symptoms, great performance status, no comorbidity, elevated LDH levels, normal Hb and white blood cell counts, high platelet counts, and were diagnosed with stage 2 disease. Most patients with Hodgkin’s Lymphoma survived for 5 years.
Stimulation Effect of Exosome From Healthy Sera to Natural Killer (NK) Cells of Hepatocellular Carcinoma Subject In Vitro Deby, Deby; Antarianto, Radiana Dhewayani; Barasila, Atikah Chalida; Irawan, Cosphiadi; Ahani, Ardhi Rahman; Jasirwan, Chyntia Olivia Maurine; Damayanti, Lia; Ritchie, Ni Ken; Aditya, Robby Nur
Indonesian Journal of Cancer Vol 18, No 4 (2024): December
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v18i4.1122

Abstract

Background: Hepatocellular carcinoma has a poor prognosis due to limitations of therapy such as late diagnosis, lack of specific biomarkers, and insensitivity to this tumor agent. This study aims to develop immunotherapy using autologous natural killer cells (NK cells) with exosome stimulation for hepatocellular carcinoma patients, addressing treatment limitations.Methods: Experimental research conducted from October 2022 to June 2023 at Universitas Indonesia’s Faculty of Medicine involved three hepatocellular carcinoma patients at Dr. Cipto Mangunkusumo General Hospital in Jakarta, Indonesia. NK cells from hepatocellular carcinoma patients were isolated from peripheral venous blood, and exosomes were isolated from the blood serum of healthy donors. Exosome characterization with a particle size analyzer and flow cytometry. Stimulation of exosomes on NK cells for 24 hours, then evaluation of expression of NKp44, NKp46, NKp30, NKG2D, KIR2D, and NKG2A receptors, as well as perforin and granzyme B expression. Visualization of interactions of NK cells with other mononuclear cell fractions (CD4, CD8, CD11c, and CD19) by immunofluorescence. The study compares stimulated and unstimulated NK cells, analyzing their expression of activated and inhibitory receptors, using either the One-Way Anova parametric test or the Kruskal-Wallis non-parametric test for non-normally distributed data.Results: Particle size 100 nm, negative electric charge, and CD63+CD81+ (double positive) exosome isolated results. There was increased expression of receptors NKp44, NKp46, NKp30, NKG2D, decreased expression of NKG2A, and increased expression of perforin and granzyme B in exosome-induced NK cells. There was no cell interaction in the form of immune synapses between exosome-induced NK cells and other mononuclear cell fractions in hepatocellular carcinoma patients. Conclusions: Induction of exosomes into NK cells of hepatocellular carcinoma patients restores the cytotoxic ability of NK cells
The Role of Tumor-Associated Macrophage Density to Tumor Size and Lymph Node Metastases of Invasive Ductal Carcinoma Patients at Dr. Soedarso General Hospital Pontianak Nugraha, Muhammad Fikri; Pratiwi, Sari Eka; Ilmiawan, Muhammad In'am; Trianto, Heru Fajar; Fitrianingrum, Iit; Hartono, Hengky
Indonesian Journal of Cancer Vol 18, No 4 (2024): December
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v18i4.1161

Abstract

Background: Invasive ductal carcinoma is the most common form of breast cancer worldwide and has a high mortality rate. The main component of the innate immune system in the tumor environment is the tumor-associated macrophage (TAM). Certain types of TAM are known to affect tumor size and lymph node metastasis which makes the cancer prognosis worse. Currently, TAM identification is generally identified using immunohistochemical staining techniques that require high costs and special expertise. An easy and inexpensive TAM identification technique is needed in determining breast cancer prognostic factors. This study focused on TAM density and its role in tumor size and lymph node metastases of invasive ductal carcinoma patients.Methods: This research is an observational analytic study using a cross-sectional approach. This study was conducted by observing the Hematoxylin-Eosin (HE) preparation of invasive ductal carcinoma patients. This study used 55 medical record data and histopathology laboratory reports of invasive ductal carcinoma patients at Dr. Soedarso General Hospital Pathological Anatomy Laboratory. TAM density cut-off is measured by calculating the median data of TAM density. Research analysis was performed using Spearman’s rho correlation test in SPSS version 24.Results: The cut-off value for determining TAM density obtained from observations based on the average value was 29. The highest number of tumor size groups was T4, and the highest number of lymph node metastases was N2. TAM density was significantly not correlated to tumor size (p = 0.285, p 0.05) and lymph node metastases (p = 0.479, p 0.05) Conclusions: This study found no significant correlation between TAM density, assessed through a cost-effective method using HE staining, and tumor size or lymph node metastasis in invasive ductal carcinoma patients.
Parathyroid Adenoma with Fibrous Dysplasia of Maxilla and Mandible in a Patient with End Stage Renal Disease (ESRD) on Routine Hemodialysis: A Case Report Lumban Tobing, Richard Sumihar Hasudungan; Azhar, Yohana
Indonesian Journal of Cancer Vol 18, No 4 (2024): December
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v18i4.1249

Abstract

Introduction: End Stage Renal Disease (ESRD) can cause secondary hyperparathyroidism, resulting in parathyroid hyperplasia. In parathyroid hyperplasia, monoclonal development can occur, resulting in nodular hyperplasia. This nodular hyperplasia was thought to develop into a carcinoma, but its development into a benign neoplasm is very rare. This case report presents a parathyroid adenoma that developed in a patient with endstage renal failure who required routine hemodialysis. Case Presentation: A 31yearold woman presented with complaints of facial bone swelling, shortened body, and a previous history of renal failure with hemodialysis therapy since 4 years ago. From the blood test, a hyperparathyroid condition was found, and a history of hypocalcemia. A sestamibi (MIBI) examination has also been done with the results of bilateral inferior parathyroid adenomas. The patient was diagnosed with bilateral inferior parathyroid adenoma with endstage renal disease (ESRD) on hemodialysis and bilateral inferior parathyroidectomy was performed on the patient. The patient’s progress was followed from diagnosis, surgery, and followup after surgery. At 4 months postoperatively, the suspicion of a mass in the residual parathyroid was confirmed by parathyroid hormone (PTH) and MIBI examination. The patient was suspected to have parathyroid hyperplasia in the remaining gland, with risk factors for hyperparathyroidism due to ESRD. Conclusions: ESRDinduced secondary hyperparathyroidism may lead to enlargement of all parathyroid glands which may develop into nodules. Therefore, careful monitoring and diagnostics supported by hospital policy is required and removal of all parathyroid glands is considered in such patients, even if not all parathyroid glands have masses.
The Relationship of Neoadjuvant Taxanes, Anthracyclines, Cyclophosphamide Chemotherapy on Nutritional Status Based on Body Mass Index (BMI) and Albumin Measurements in Locally Advanced Stage Breast Cancer Patients in Bahteramas Hospital Kendari S Limba, Afirah Khairunnisa; Royani, Ida; Muchsin, Achmad Harun; Kamaluddin, Irna Diyana Kartika; Irsandy, Febie
Indonesian Journal of Cancer Vol 18, No 4 (2024): December
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v18i4.1283

Abstract

Background: Breast cancer is a disease caused by cancer cells in breast tissue. The most frequently found is locally advanced. The locally advanced stage refers to stages IIIA, IIIB, and IIIC. Neoadjuvant is the treatment for locally advanced. The Taxane, Anthracycline, and Cyclophosphamide (TAC) is a neoadjuvant chemotherapy regimen that can cause nausea and vomiting resulting in decreased appetite and lack of nutritional intake in patients. This study aims to determine the relationship between neoadjuvant TAC chemotherapy and nutritional status based on measurements of BMI and albumin in breast cancer patients at Bahteramas Kendari Hospital.Method: This study was conducted with a retrospective cross-sectional design. The sampling technique was consecutive sampling using 41 medical records of breast cancer patients from the years 2023 to 2024 in Bahteramas Kendari Hospital.Result: There were significant changes in the nutritional status of patients who received neoadjuvant TAC chemotherapy. Before chemotherapy, the patient’s BMI was found to be in the normal category of 34.1% and decreased to 31.7% after chemotherapy. Likewise, patients with obesity were 34.1% before chemotherapy and changed to 19.5% after chemotherapy. Furthermore, there were significant changes in the patient’s albumin levels. Before chemotherapy, 38 patients had normal albumin levels (92.7%), whereas after chemotherapy only 24 patients had normal albumin levels (58.5%).Conclusion: There was a relationship between TAC neoadjuvant chemotherapy and nutritional status based on BMI and Albumin measurements before and after chemotherapy in patients with locally advanced breast cancer.

Filter by Year

2007 2025


Filter By Issues
All Issue Vol 19, No 3 (2025): September Vol 19, No 2 (2025): June Vol 19, No 1 (2025): March Vol 18, No 4 (2024): December Vol 18, No 3 (2024): September Vol 18, No 2 (2024): June Vol 18, No 1 (2024): March Vol 17, No 4 (2023): December Vol 17, No 3 (2023): September Vol 17, No 2 (2023): June Vol 17, No 1 (2023): March Vol 16, No 4 (2022): December Vol 16, No 3 (2022): September Vol 16, No 2 (2022): June Vol 16, No 1 (2022): March Vol 15, No 4 (2021): December Vol 15, No 3 (2021): September Vol 15, No 2 (2021): June Vol 15, No 1 (2021): March Vol 14, No 4 (2020): December Vol 14, No 3 (2020): September Vol 14, No 2 (2020): June Vol 14, No 1 (2020): March Vol 13, No 4 (2019): December Vol 13, No 3 (2019): September Vol 13, No 2 (2019): June Vol 13, No 1 (2019): March Vol 12, No 4 (2018): October-December Vol 12, No 3 (2018): July-September Vol 12, No 2 (2018): April-June Vol 12, No 1 (2018): Jan - Mar Vol 11, No 4 (2017): October- December 2017 Vol 11, No 3 (2017): July - September 2017 Vol 11, No 2 (2017): April - June Vol 11, No 1 (2017): Jan-Mar Vol 10, No 4 (2016): October - December 2016 Vol 10, No 3 (2016): July - September 2016 Vol 10, No 2 (2016): April - June 2016 Vol 10, No 1 (2016): Jan - Mar 2016 Vol 9, No 4 (2015): Okt - Des 2015 Vol 9, No 3 (2015): Jul - Sept 2015 Vol 9, No 2 (2015): April-Juni 2015 Vol 9, No 1 (2015): Jan - Mar 2015 Vol 8, No 4 (2014): Oct - Dec 2014 Vol 8, No 3 (2014): Jul - Sep 2014 Vol 8, No 2 (2014): April-Juni 2014 Vol 8, No 1 (2014): Jan - Mar 2014 Vol 7, No 4 (2013): Oct - Dec 2013 Vol 7, No 3 (2013): Jul - Sep 2013 Vol 7, No 2 (2013): Apr - Jun 2013 Vol 7, No 1 (2013): Jan - Mar 2013 Vol 6, No 4 (2012): Oct - Dec 2012 Vol 6, No 3 (2012): Jul - Sep 2012 Vol 6, No 2 (2012): Apr - Jun 2012 Vol 6, No 1 (2012): Jan - Mar 2012 Vol 5, No 4 (2011): Oct - Dec 2011 Vol 5, No 3 (2011): Jul - Sep 2011 Vol 5, No 2 (2011): Apr - Jun 2011 Vol 5, No 1 (2011): Jan - Mar 2011 Vol 4, No 4 (2010): Oct - Dec 2010 Vol 4, No 3 (2010): Jul - Sep 2010 Vol 4, No 2 (2010): Apr - Jun 2010 Vol 4, No 1 (2010): Jan - Mar 2010 Vol 3, No 4 (2009): Oct - Dec 2009 Vol 3, No 3 (2009): Jul - Sep 2009 Vol 3, No 2 (2009): Apr - Jun 2009 Vol 3, No 1 (2009): Jan - Mar 2009 Vol 2, No 4 (2008): Oct - Dec 2008 Vol 2, No 3 (2008): Jul - Sep 2008 Vol 2, No 2 (2008): Apr - Jun 2008 Vol 2, No 1 (2008): Jan - Mar 2008 Vol 1, No 4 (2007): Oct - Dec 2007 Vol 1, No 3 (2007): Jul - Sep 2007 Vol 1, No 2 (2007): Apr - Jun 2007 Vol 1, No 1 (2007): Jan - Mar 2007 More Issue